Skip to main content
. 2018 Aug 24;7(8):64. doi: 10.1038/s41389-018-0075-1

Fig. 2. Mitochondrial metabolic rate under the influence of Neratinib and Mubritinib.

Fig. 2

SK-BR3 cells treated with the indicated concentrations of Neratinib over a time period of 24 h, 48 h, or 72 h (a). BT474 cells treated with the indicated concentrations of Neratinib over a time period of 24 h, 48 h, or 72 h (b). SK-BR3 cells treated with the indicated concentrations of Mubritinib over a time period of 24 h, 48 h or 72 h (c). BT474 cells treated with the indicated concentrations of Mubritinib over a time period of 24 h, 48 h, or 72 h (d). (N = 3)